newsfilter
← Latest News
Business Wire·

ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock

ImmunoGen Inc. (NASDAQ:IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced the pricing of an underwritten public offering of 26,000,000 shares of its